Arteriovenous malformations and other vascular malformation syndromes

Cold Spring Harbor Perspectives in Medicine

Volumn 3, Issue 2, 2013, Pages

  Whitehead, Kevin J ^a,b   Smith, Matthew C P ^a,b   Li, Dean Y ^a,b  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERIOVENOUS MALFORMATION; BRAIN HEMANGIOMA; CAPILLARY; CONGENITAL MALFORMATION; GENETICS; HUMAN; MUCOSA; MUTATION; RENDU OSLER WEBER DISEASE; REVIEW; SKIN; SKIN BLOOD VESSEL DISORDER; VASCULARIZATION;

ARTERIOVENOUS MALFORMATIONS; CAPILLARIES; HEMANGIOMA, CAVERNOUS, CENTRAL NERVOUS SYSTEM; HUMANS; MUCOUS MEMBRANE; MUTATION; SKIN; SKIN DISEASES, VASCULAR; TELANGIECTASIA, HEREDITARY HEMORRHAGIC;

MLCS; MLOWN;

EID: 84878976353     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a006635     Document Type: Article

References (62)

1. Al-Shahi R, Warlow C. 2001. A systematic review of the frequency and prognosis of arteriovenous malformations of the brain in adults. Brain 124: 1900-1926.
2. Arthur H.M., Ure J, Smith AJ, Renforth G, Wilson DI, Torsney E, Charlton R, Parums DV, Jowett T, Marchuk DA, et al. 2000. Endoglin, an ancillary TGFβ receptor, is required for extraembryonic angiogenesis and plays a key role in heart development. Dev Biol 217: 42-53.
3. Battle T.E., Lynch RA, Frank DA. 2006. Signal transducer and activator of transcription 1 activation in endothelial cells is a negative regulator of angiogenesis. Cancer Res 66: 3649-3657.
4. Benjamin L.E., Golijanin D, Itin A, Pode D, Keshet E. 1999. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J Clin Invest 103: 159-165.
5. Bergametti F., Denier C, Labauge P, Arnoult M, Boetto S, Clanet M., Coubes P, Echenne B, Ibrahim R, Irthum B, et al. 2005. Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations. Am J Hum Genet 76: 42-51.
6. Boon L.M., Mulliken JB, Vikkula M. 2005. RASA1: Variable phenotype with capillary and arteriovenous malformations. Curr Opin Genet Dev 15: 265-269.
7. Bourdeau A., Dumont DJ, Letarte M. 1999. A murine model of hereditary hemorrhagic telangiectasia. J Clin Invest 104: 1343-1351.
8. Brouillard P., Vikkula M. 2003. Vascular malformations: Localized defects in vascular morphogenesis. Clin Genet 63: 340-351.
9. Buscarini E., Danesino C, Olivieri C, Lupinacci G, Zambelli A. 2005. Liver involvement in hereditary haemorrhagic telangiectasia or Rendu-Osler-Weber disease. Dig Liver Dis 37: 635-645.
10. Clatterbuck R.E., Eberhart CG, Crain BJ, Rigamonti D. 2001. Ultrastructural and immunocytochemical evidence that an incompetent blood-brain barrier is related to the pathophysiology of cavernous malformations. J Neurol Neurosurg Psychiatry 71: 188-192.
11. Cura M., Elmerhi F, Suri R, Bugnone A, Dalsaso T. 2010. Vascular malformations and arteriovenous fistulas of the kidney. Acta Radiol 51: 144-149.
12. David L., Mallet C, Mazerbourg S, Feige JJ, Bailly S. 2007. Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. Blood 109: 1953-1961.
13. Denier C., Goutagny S, Labauge P, Krivosic V, Arnoult M, Cousin A., Benabid AL, Comoy J, Frerebeau P, Gilbert B, et al. 2004. Mutations within the MGC4607 gene cause cerebral cavernous malformations. Am J Hum Genet 74: 326-337.
14. Eerola I., Boon LM, Mulliken JB, Burrows PE, Dompmartin A, Watanabe S, Vanwijck R, Vikkula M. 2003. Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations. Am J Hum Genet 73: 1240-1249.
15. Etienne-Manneville S, Hall A. 2002. Rho GTPases in cell biology. Nature 420: 629-635.
16. Faurobert E., Albiges-Rizo C. 2009. Recent insights into cerebral cavernous malformations: Acomplex jigsaw puzzle under construction. FEBS J 277: 1084-1096.
17. Frech M., John J, PizonV, Chardin P, Tavitian A, Clark R, Mc-Cormick F., Wittinghofer A. 1990. Inhibition of GTPase activating protein stimulation of Ras-p21 GTPase by the Krev-1 gene product. Science 249: 169-171.
18. Gallione C.J., Repetto GM, Legius E, Rustgi AK, Schelley SL, Tejpar S., Mitchell G, Drouin E, Westermann CJ, Marchuk DA. 2004. A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). Lancet 363: 852-859.
19. Glading A.J., Ginsberg MH. 2010. Rap1 and its effector KRIT1/CCM1 regulate β-catenin signaling. Dis Model Mech 3: 73-83.
20. Glading A., Han J, Stockton RA, Ginsberg MH. 2007. KRIT-1/CCM1 is a Rap1 effector that regulates endothelial cell cell junctions. J Cell Biol 179: 247-254.
21. Gore A.V., Lampugnani MG, Dye L, Dejana E, Weinstein BM. 2008. Combinatorial interaction between CCM pathway genes precipitates hemorrhagic stroke. DisModelMech 1: 275-281.
22. Goudreault M., D'Ambrosio LM, Kean MJ, Mullin MJ, Larsen B.G., Sanchez A, Chaudhry S, Chen GI, Sicheri F, Nesvizhskii A.I., et al. 2009. A PP2A phosphatase high density interaction network identifies a novel striatininteracting phosphatase and kinase complex linked to the cerebral cavernous malformation 3 (CCM3) protein. Mol Cell Proteomics 8: 157-171.
23. Govani F.S., Shovlin CL. 2009. Hereditary haemorrhagic telangiectasia: A clinical and scientific review. Eur J Hum Genet 17: 860-871.
24. Guttmacher A.E., Marchuk DA, White RI Jr. 1995. Hereditary hemorrhagic telangiectasia. N Engl J Med 333: 918-924.
25. Hilder T.L., Malone MH, Bencharit S, Colicelli J, Haystead TA, Johnson GL, Wu CC. 2007. Proteomic identification of the cerebral cavernous malformation signaling complex. J Proteome Res 6: 4343-4355.
26. Hu H.T., Huang YH, Chang YA, Lee CK, Jiang MJ, Wu LW. 2008. Tie2-R849W mutant in venous malformations chronically activates a functional STAT1 to modulate gene expression. J Invest Dermatol 128: 2325-2333.
27. Ishihara T., Hirooka M, Ono T. 1997. Arteriovenous malformation in the buttock: Treatment with a combination of selective embolization and excision. J Dermatol 24: 787-792.
28. Jaffe A.B., Hall A, Schmidt A. 2005. Association of CNK1with Rho guanine nucleotide exchange factors controls signaling specificity downstream of Rho. Curr Biol 15: 405-412.
29. Johnson D.W., Berg JN, Baldwin MA, Gallione CJ, Marondel I, Yoon SJ, Stenzel TT, Speer M, Pericak-Vance MA, Diamond A., et al. 1996. Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet 13: 189-195.
30. Karnoub A.E., Weinberg RA. 2008. Ras oncogenes: Split personalities. Nat Rev Mol Cell Biol 9: 517-531.
31. Labauge P., Brunereau L, Levy C, Laberge S, Houtteville JP. 2000. The natural history of familial cerebral cavernomas: A retrospective MRI study of 40 patients. Neuroradiology 42: 327-332.
32. Laberge-le Couteulx S, Jung HH, Labauge P, Houtteville JP, Lescoat C., Cecillon M, Marechal E, Joutel A, Bach JF, Tournier-Lasserve E. 1999. Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas. Nat Genet 23: 189-193.
33. Li D.Y., Sorensen LK, Brooke BS, Urness LD, Davis EC, Taylor DG, Boak BB, WendelDP. 1999. Defective angiogenesis in mice lacking endoglin. Science 284: 1534-1537.
34. Limaye N., Boon LM, Vikkula M. 2009a. From germline towards somatic mutations in the pathophysiology of vascular anomalies. Hum Mol Genet 18: R65-R74.
35. Limaye N., Wouters V, Uebelhoer M, Tuominen M, Wirkkala R, Mulliken JB, Eklund L, Boon LM, Vikkula M. 2009b. Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations. Nat Genet 41: 118-124.
36. Liquori C.L., Berg MJ, Siegel AM, Huang E, Zawistowski JS, Stoffer T., Verlaan D, Balogun F, Hughes L, Leedom TP, et al. 2003. Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations. Am J Hum Genet 73: 1459-1464.
37. Matsushige T., Kiya K, Satoh H, Mizoue T, Kagawa K, Araki H. 2004. Arteriovenous malformation of the scalp: Case report and review of the literature. Surg Neurol 62: 253-259.
38. McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE, Helmbold EA, Markel DS, McKinnon WC, Murrell J, et al. 1994. Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 8: 345-351.
39. Neptune E.R., Frischmeyer PA, Arking DE, Myers L, Bunton TE, Gayraud B, Ramirez F, Sakai LY, Dietz HC. 2003. Dysregulation of TGF-β activation contributes to pathogenesis in Marfan syndrome. Nat Genet 33: 407-411.
40. Oh S.P., Seki T, Goss KA, Imamura T, Yi Y, Donahoe PK, Li L, Miyazono K., ten Dijke P, Kim S, et al. 2000. Activin receptor-like kinase 1 modulates transforming growth factor-β 1 signaling in the regulation of angiogenesis. Proc Natl Acad Sci 97: 2626-2631.
41. Osler W. 1900. On a family form of recurring epistaxis, associated with multiple telangiectases of the skin and mucousmembranes. Bull JohnsHopkinsHosp 12: 333-337.
42. Otten P., Pizzolato GP, Rilliet B, Berney J. 1989. A propos de 131 cas d'angiomes caverneux (cavernomes) du S.N.C. repérés par l'analyse rétrospective de 24 535 autopsies. Neurochirurgie 35: 82-83, 128-131.
43. Park S.O., Wankhede M, Lee YJ, Choi EJ, Fliess N, Choe SW, Oh S.H., Walter G, Raizada MK, Sorg BS, et al. 2009. Realtime imaging of de novo arteriovenous malformation in a mouse model of hereditary hemorrhagic telangiectasia. J Clin Invest 119: 3487-3496.
44. Petit N., Blecon A, Denier C, Tournier-Lasserve E. 2006. Patterns of expression of the three cerebral cavernous malformation (CCM) genes during embryonic and postnatal brain development. Gene Expr Patterns 6: 495-503.
45. Rendu H. 1896. É pistaxis répétées chez un sujet porteur de petits angiomes cutanés et muqueux. Bull Mem Soc Med Hop Paris 13: 731-733.
46. Riant F., Bergametti F, Ayrignac X, Boulday G, Tournier-Lasserve E. 2009. Recent insights into cerebral cavernous malformations: The molecular genetics of CCM. FEBS J 277: 1070-1075.
47. Sahoo T., Johnson EW, Thomas JW, Kuehl PM, Jones TL, Dokken C.G., Touchman JW, Gallione CJ, Lee-Lin SQ, Kosofsky B., et al. 1999. Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1). Hum Mol Genet 8: 2325-2333.
48. Scharpfenecker M., van Dinther M, Liu Z, van Bezooijen RL, Zhao Q., Pukac L, Lowik CW, ten Dijke P. 2007. BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis. J Cell Sci 120: 964-972.
49. Serebriiskii I., Estojak J, Sonoda G, Testa JR, Golemis EA. 1997. Association of Krev-1/rap1a with Krit1, a novel ankyrin repeat-containing protein encoded by a gene mapping to 7q21-22. Oncogene 15: 1043-1049.
50. Settleman J., Albright CF, Foster LC, Weinberg RA. 1992a. Association between GTPase activators for Rho and Ras families. Nature 359: 153-154.
51. Settleman J., Narasimhan V, Foster LC, Weinberg RA. 1992b. Molecular cloning of cDNAs encoding the GAP-associated protein pp190: Implications for a signaling pathway from ras to the nucleus. Cell 69: 539-549.
52. Shovlin C.L., Guttmacher AE, Buscarini E, Faughnan ME, Hyland R.H., Westermann CJ, Kjeldsen AD, Plauchu H. 2000. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 91: 66-67.
53. Sorensen L.K., Brooke BS, LiDY, Urness LD. 2003. Loss of distinct arterial and venous boundaries in mice lacking endoglin, a vascular-specific TGFβ coreceptor. Dev Biol 261: 235-250.
54. Stockton R.A., Shenkar R, Awad IA, Ginsberg MH. 2010. Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity. J Exp Med 207: 881-896.
55. Terry P.B., Barth KH, Kaufman SL, White RI Jr. 1980. Balloon embolization for treatment of pulmonary arteriovenous fistulas. N Engl J Med 302: 1189-1190.
56. UhlikMT, Abell AN, Johnson NL, SunW, CuevasBD, Lobel-Rice K.E., Horne EA, Dell'Acqua ML, Johnson GL. 2003. Rac-MEKK3-MKK3 scaffolding for pp38 MAPK activation during hyperosmotic shock. Nat Cell Biol 5: 1104-1110.
57. Urness L.D., Sorensen LK, LiDY. 2000. Arteriovenous malformations in mice lacking activin receptor-like kinase-1. Nat Genet 26: 328-331.
58. VernooijMW, Ikram MA, Tanghe HL, Vincent AJ, Hofman A, Krestin GP, Niessen WJ, Breteler MM, van der Lugt A. 2007. Incidental findings on brain MRI in the general population. N Engl J Med 357: 1821-1828.
59. Weber FP. 1907. Multiple hereditary developmental angiomata (telangiectases) of the skin and mucous membranes associated with recurring haemorrhages. Lancet 2: 160-162.
60. Whitehead K.J., Chan AC, Navankasattusas S, Koh W, London NR, Ling J, Mayo AH, Drakos SG, Marchuk DA, Davis G.E., et al. 2009. The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases. Nat Med 15: 177-184.
61. Wouters V., Limaye N, Uebelhoer M, Irrthum A, Boon LM, Mulliken J.B., Enjolras O, Baselga E, Berg J, Dompmartin A, et al. 2009. Hereditary cutaneomucosal venous malformations are caused by TIE2 mutations with widely variable hyper-phosphorylating effects. Eur J Hum Genet 18: 414-420.
62. Zheng X., Xu C, Di Lorenzo A, Kleaveland B, Zou Z, Seiler C, Chen M., Cheng L, Xiao J, He J, et al. 2010. CCM3 signaling through sterile 20-like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations. J Clin Invest 120: 2795-2804.